StockData
AEON Biopharma, Inc. logo

AEON Biopharma, Inc. (AEON) stock

AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.12+0.01 (+9.61%)

Close on Nov 18, 2026Market cap $6.20MP/E –Yield –

AEON Biopharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

AEON Biopharma's pe ratio was 0.2× on Jan 30, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 20260.2×+0.0
2025Dec 31, 20250.2×–

More AEON Biopharma figures

See a number that looks wrong?